HRSA-23-083: Life Course Translational Research Network (LCT-RN)
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2023.
Health Resources and Services Administration offered grants of up to $800,000 to the applicants described in the notice. It expected to make one award worth $800,000 in total. Applications closed on April 10, 2023.
From the official notice on Grants.gov, last changed January 10, 2023. Checked November 7, 2026.
- Award ceiling$800,000
- Total funding$800,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | January 9, 2023 |
|---|---|
| Deadline | April 10, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is limited to public or non-profit institutions of higher learning and public or private non-profit agencies engaged in research or in programs relating to maternal and child health and/or services for children with special health care needs. See 42 CFR 51a.3(b). Faith-based and community-based organizations, tribes, and tribal organizations are eligible to apply. You are required to submit proof of non-profit status as Attachment 5, if applicable. A foreign applicant will need to be affiliated with a U.S. entity (i.e., university, institution)with a U.S. EIN established and recognized by HRSA to be considered a public or nonprofit institution of higher learning or a public or private nonprofit agency.
Is this a realistic fit?
- Past Special Projects of Regional and National Significance awards averaged $1.6 million; this notice allows up to $800,000 per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the FY 2023 Life Course Translational Research Network (LCT-RN) Program. The purpose of this program is to establish and maintain an interdisciplinary, national, multi-site research platform for scientific collaboration and infrastructure building to conduct timely, innovative, high-quality, applied life course intervention1 research studies that have the potential to be translated3 into practice. The LCT-RN will promote child health and health equity2 across the lifespan. The findings from these studies are expected to inform MCHB program planning, policymaking, and evidence-based practice from a life course perspective. Life course translational research considers the health and well-being of the whole child in the context of the family and broader ecological levels,4 identifies strategic opportunities to intervene, and translates findings into practice to improve population health. In this funding cycle, LCT-RN will place a high priority on studies that focus on health equity and how maternal, paternal, and family physical and mental health affects child health, recognizing the importance of two-generation models5 for influencing intergenerational health. The LCT-RN will collaborate with HRSA MCHB-funded programs to identify priority topics, implement multi-site intervention studies, and translate findings into practice. The objectives of the LCT-RN to be completed during the 5-year period of performance are to: • Grow and expand an interdisciplinary, national, multi-site, collaborative translational research network that will accelerate the translation of life course research into practice and reduce health disparities in MCH populations; • Conduct at least five intervention research studies that apply life course theory, have the potential to modify health development at critical life stages, and can be translated into public health practice; • Develop strategic collaborations to inform research priorities and ensure activities are responsive to the needs of underserved communities; • Train and mentor at least 10 junior/new investigators annually including those from underserved communities and/or those from minority-serving institutions; and • Disseminate research findings including at least five peer-reviewed publications per year; and evaluate the impact of research activities on programs, practices, and policy. For more details, see Program Requirements and Expectations.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-083 still open?
No. It closed on April 10, 2023. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Life Course Translational Research Network (LCT-RN)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Life Course Translational Research Network (LCT-RN)?
Closed April 10, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $800,000 each. About $800,000 in total for one award.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)